Latest filing published 05 Oct 2020 for Mimedx Group, INC., €149k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -14.8%Entry US$1.35 · Close at T+365 US$1.15
- +47.1%Entry US$0.68 · Close at T+365 US$1.00
- +23.7%Entry US$0.80 · Close at T+365 US$0.99
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Charles E. Koob: trading record in brief
This profile gathers the share dealings of Charles E. Koob across 2 companies, led by Mimedx Group, Inc. and ClearPoint Neuro, Inc. In total, 48 filings cover trades dated from 20 February 2009 to 2 October 2020.
In open-market terms, that means 4 purchases worth €48k on one side and 1 sale worth €401k on the other. The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 33 share grants and 2 option exercises.
The median purchase comes to €5,028. After 3 purchases with a full 90-day history, the hit rate stands at 67% and the median 90-day move at +25.0%. This is a record of the past, not a forecast.
The record was last updated on 5 October 2020 with a share grant (€149k) in Mimedx Group, Inc. The most recent open-market purchase was published on 21 December 2015, 3,976 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Charles E. Koob
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 26,236 shares@ US$6.6790.2% of flowCommon StockSEC:0001376339-20-000127:0
- 50,000 shares0Common StockSEC:0001376339-20-000107:0
- 50,000 shares0Common StockSEC:0001376339-20-000107:1
- 29,661 shares0Common StockSEC:0001376339-20-000089:0
- 15,000 shares0Common StockSEC:0001376339-20-000002:1
- 15,000 shares0Common StockSEC:0001376339-20-000002:2
- 15,000 shares@ US$1.209.8% of flowCommon StockSEC:0001376339-20-000002:0
- 723,154 shares0Common StockSEC:0001376339-19-000041:0
- 723,154 shares0Common StockSEC:0001376339-19-000041:1
- 2,729 shares@ US$2.4718.7% of flowCommon StockSEC:0001534424-17-000419:0
- 12,153 shares0Common StockSEC:0001376339-17-000100:0
- 140,168 shares@ US$13.1474.9% of flowCommon StockSEC:0001376339-17-000076:0
- 50,486 shares@ US$8.5017.8% of flowCommon StockSEC:0001376339-17-000048:0
- 2,749 shares@ US$2.6422.3% of flowCommon StockSEC:0001534424-17-000012:0
- 1,014 shares@ US$6.6519.6% of flowCommon StockSEC:0001534424-16-001072:0
- 32,491 shares@ US$0.2120.0% of flowCommon StockSEC:0001534424-16-000862:0
- 21,429 shares0Common StockSEC:0001376339-16-000179:0
- 21,945 shares@ US$0.3119.5% of flowCommon StockSEC:0001534424-16-000682:0
- 19,097 sharesCommon StockSEC:0001534424-16-000489:0
- 154,035 sharesCommon StockSEC:0001534424-15-000459:0Canonical exit: 17 Mar 2016 (T+90)
- 11,252 shares@ US$0.60Common StockSEC:0001534424-15-000315:0
- 6,266 shares@ US$1.08Common StockSEC:0001534424-15-000158:0
- 12,878 shares0Common StockSEC:0001376339-15-000068:0
- 7,250 shares@ US$1.00Common StockSEC:0001437749-15-006730:0
- 8,410 shares@ US$0.862Common StockSEC:0001437749-15-000182:0
25 of 48 declarations
